Abstract
NinetyEnterobacter cloacae strains isolated from 12 Greek hospitals were examined in terms of epidemiological types and resistance mechanisms. Using O serotyping 69 % of the strains were assigned to a specific serotype and overall 16 different serotypes were identified. The combination of serotyping, phagetyping and biotyping efficiently discriminated most of the strains, indicating that single epidemic strains were not prevalent, although serotypes 3, 7, and group II predominated. Eight representative strains, all resistant to gentamicin, tobramycin, amikacin and netilmicin, were further examined for transferability and mechanisms of resistance. Aminoglycoside resistance was found to be transferable in most strains, and 13 R plasmids of 40–120 MDa molecular weight were detected. The enzymes detected consisted of three enzymes active against gentamicin [ANT(2″), AAC(3)-I and AAC(3)-V]; three active against tobramycin [ANT(2″), AAC(3)-V and AAC(6′)-I]; two active against netilmicin [AAC(3)-V and AAC(6′)-I]; and one active against amikacin [AAC(6′)-I]. APH(3′) and ANT (3″), which modify neomycin and streptomycin plus spectinomycin respectively, were also found. Overall up to five aminoglycoside modifying enzymes were detected on the same R plasmid, AAC(6′)-I plus ANT(2″) being the most prevalent. The high incidence of multiresistance inEnterobacter cloacae and the fact that resistance is due to enzymatic inactivation of the antibiotics, indicate that in Greece this species might act as a gene pool for the spread of resistance to other bacteria of clinical relevance.
Similar content being viewed by others
References
Gaston MA:Enterobacter: an emerging nosocomial pathogen. Journal of Hospital Infection 1988, 11: 197–208.
Murray PH, Granich GG, Krogstad DJ, Niles AC: In vitro selection of resistance to multiple cephalosporins byEnterobacter cloacae. Journal of Infectious Diseases 1983, 147: 590.
Sanders CC, Sanders WE: Microbial resistance to newer generation β-lactam antibiotics: clinical and laboratory implications. Journal of Infectious Diseases 1985, 151: 399–406.
Mayer KH, Hopkins JD, Gilleece ES, Chao L, O'Brien TF: Molecular evolution, species distribution and clinical consequences of an endemic aminoglycoside resistance plasmid. Antimicrobial Agents and Chemotherapy 1986, 29: 628–633.
The Greek Society for Microbiology: Antibiotic resistance among gram-negative bacilli in 19 Greek hospitals. Journal of Hospital Infection 1989, 14: 177–181.
Legakis NJ, Koukoubanis N, Malliara K, Michalitsianos D, Papavassiliou J: Importance of carbenicillin and gentamicin cross resistant serotype O:12Pseudomonas aeruginosa in six Athens hospitals. European Journal of Clinical Microbiology 1987, 6: 300–303.
Pitt TL, Livermore DM, Pitcher D, Vatopoulos AC, Legakis NJ: Multiresistant serotype O:12Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiology and Infection 1989, 103: 565–576.
Vatopoulos AC, Phillipon A, Tzouvelekis LS, Komninou Z, Legakis NJ: Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates ofKlebsiella pneumoniae andEscherichia coli in Greece. Journal of Antimicrobial Chemotherapy 1990, 26: 635–648.
Gaston MA, Bucher C, Pitt TL: O serotyping scheme forEnterobacter cloacae. Journal of Clinical Microbiology 1983, 18: 1079–1083.
Gaston MA: Evaluation of a bacteriophage-typing scheme forEnterobacter cloacae. Journal of Medical Microbiology 1987, 24: 291–295.
Gaston MA, Crees-Morris JA, Pitt TL: Serotypes and biochemical profiles of British hospital strains ofEnterobacter cloacae in relation to site of infection and antibiotic susceptibility. Journal of Hospital Infection 1987, 10: 17–27.
Elwell LP, Falkow S: The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V (ed): Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, 1986, p. 683–721.
Takahashi S, Nagano Y: Rapid procedure for the isolation of plasmid DNA and application to epidemiological analysis. Journal of Clinical Microbiology 1984, 20: 608–613.
Olsen JE: An improved method for rapid isolation of plasmid DNA from wild-type gram-negative bacteria for plasmid restriction profile analysis. Letters in Applied Microbiology 1990, 10: 209–212.
Miller GH, Hare RS, Moos EL, Sabatelli FJ, Waitz JA: Survey on aminoglycoside resistance patterns. Developments in Industrial Microbiology 1980, 21: 91–104.
Shimizu K, Kumada T, Hsieh WC, Chung HY, Chong Y, Hare RS, Miller GH, Sabatelli FS, Howard J: Comparison of aminoglycoside resistance patterns in Japan, Formosa, Korea, Chile and the United States. Antimicrobial Agents and Chemotherapy 1985, 28: 282–288.
Tenover FC, Gootz TD, Gordon KP, Tompkins LS, Young SA, Plorde JJ: Development of a DNA probe for the structural gene of the 2″-O-adenyltransferase aminoglycoside-modifying enzyme. Journal of Infectious Diseases 1984, 150: 678–687.
Tenover FC, Filpula D, Phillips KL, Plorde JJ: Cloning and sequencing of a gene encoding an aminoglycoside 6′-N-acetyltransferase from an R factor ofCitrobacter diversus. Journal of Bacteriology 1988, 170: 471–473.
Tran Van Nheiu G, Collatz E: Primary structure of an aminoglycoside 6′-N-acetyltransferase AAC(6′)-4 fused in vivo with the signal peptide of the Tn3-encoded beta-lactamase. Journal of Bacteriology 1987, 159: 5708–5714.
Tenover FC, Fillips KL, Gilbert T, Lockhart P, O'Hara PJ, Plorde JJ: Development of a DNA probe from the deoxyribonucleotide sequence of the 3-N-aminoglycoside acetyltransferase (AAC(3)-I) resistance gene. Antimicrobial Agents and Chemotherapy 1989, 33: 551–559.
Barg NL: Construction of a probe for the aminoglycoside 3-V-acetyltransferase gene and detection of the gene among endemic clinical isolates. Antimicrobial Agents and Chemotherapy 1988, 32: 1834–1838.
Grindley NDF, Joyce CM: Genetic and DNA sequence analysis of the kanamycin resistance transposon Tn903. Proceedings of the National Academy of Sciences of the USA. 1980, 77: 7176–7180.
Young SA, Tenover FC, Gootz TD, Gordon KP, Plorde JJ: Development of two DNA probes for differentiating the structural gene of subclasses I and II of the aminoglycoside-modifying enzyme 3′-aminoglycoside phosphotransferase. Antimicrobial Agents and Chemotherapy 1985, 27: 739–744.
Martin P, Julien E, Courvalin P: Nucleotide sequence ofAcinetobacter baumannii aphA-6 gene: evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes. Molecular Microbiology 1988, 2: 615–625.
Pitt TL, Livermore DM, Miller G, Vatopoulos A, Legakis NJ: Resistance mechanisms of multiresistant serotype O:12Pseudomonas aeruginosa isolated in Europe. Journal of Antimicrobial Chemotherapy 1990, 26: 319–328.
Markowitz SM, Smith SM, Williams DS: Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due toEnterobacter cloacae. Journal of Infectious Diseases 1983, 148: 18–23.
Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Ganetou KG, Mostrou GI:Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infection Control 1984, 5: 471–477.
Flynn DM, Weinstein RA, Nathan C, Gaston MA, Kabins SA: Patients' endogenous flora as a source of “nosocomial”Enterobacter in cardiac surgery. Journal of Infectious Diseases 1987, 165: 363–368.
Phillips J, Shannon K: Aminoglycoside resistance. British Medical Bulletin 1984, 40: 28–35.
Groot Obbink DJ, George AM, Coombe RG: Aminoglycoside modifying enzymes associated with hospital isolates of gram-negative rods. Journal of Antimicrobial Chemotherapy 1983, 11: 525–533.
Kettner M, Navarova J, Rydl Z, Knothe H, Lebek G, Kremery V: Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria andPseudomonas aeruginosa from several countries. Journal of Antimicrobial Chemotherapy 1981, 8: 175–181.
Dornbusch K, Miller GH, Hare RS, Shaw KJ, andthe ESGAR Study Group: Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European colaborative study. Journal of Antimicrobial Chemotherapy 1990, 25: 131–144.
Kawabe H, Naito T, Mitsuhashi S: Acetylation of amikacin, a new semisynthetic antibiotic byPseudomonas aeruginosa carrying an R factor. Antimicrobial Agents and Chemotherapy 1975, 7: 50–54.
Betts RF, Valenti WM, Chapman SW, Chonmaitree T, Mowrer G, Pincus P, Messner M, Robertson R: Five year surveillance of aminoglycoside usage in a university hospital. Annals of Internal Medicine 1984, 100: 219–222.
Moody M, de Jongh CA, Schimpff SC, Tillman GL: Long term amikacin use: effects on aminoglycoside susceptibility patterns of gram-negative bacilli. Journal of the American Medical Association 1982, 248: 1199–1202.
Levine JF, Maslow MJ, Leibowitz RE, Pollock AA, Hanna BA, Schaefler S, Simberkoff MS, Rahal JJ: Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. Journal of Infectious Diseases 1985, 151: 295–300.
Tran Van Nhieu G, Goldstein FW, Pinto ME, Acar JF, Collatz E: Transfer of amikacin resistance by closely related plasmids in members of the familyEnterobacteriaceae isolated in Chile. Antimicrobial Agents and Chemotherapy 1986, 29: 833–837.
Kayser FH, Berger-Bachi B: Transposon transfer of drug resistance. In: Jackson GG, Schumberger HD, Zeiler HJ (ed): Prospectives in antiinfective therapy. Vieweg, Wiesbaden, 1989, p. 109–114.
Wiedemann B: Genetic and biochemical basis of resistance ofEnterobacteriaceae to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 18, Supplement B: 31–38.
Levesque RC, Jacoby GA: Molecular structure and interrelationships of multiresistant β-lactamase transposons. Plasmid 1988, 19: 21–29.
Barg N, Moyer R: Persistence of an aminoglycoside-resistance determinant at a university hospital for 12 years. Journal of Infectious Diseases 1987, 155: 586–589.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vatopoulos, A.C., Tsakris, A., Tzouvelekis, L.S. et al. Diversity of aminoglycoside resistance inEnterobacter cloacae in Greece. Eur. J. Clin. Microbiol. Infect. Dis. 11, 131–138 (1992). https://doi.org/10.1007/BF01967064
Issue Date:
DOI: https://doi.org/10.1007/BF01967064